R

Robert H. Vonderheide

University of Pennsylvania

ORCID: 0000-0002-7252-954X

Publishes on Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, Pancreatic and Hepatic Oncology Research. 800 papers and 45.5k citations.

PubIndex Score98Top 2%How it's scored

800Publications

45.5kTotal Citations

First publication: 1988First senior author: 2001

Cancer Immunotherapy and Biomarkers Immunotherapy and Immune Responses Pancreatic and Hepatic Oncology Research CAR-T cell therapy research Cancer Cells and Metastasis

Top publicationsby citations

Induction of T-cell Immunity Overcomes Complete Resistance to PD-1 and CTLA-4 Blockade and Improves Survival in Pancreatic Carcinoma

Rafael Winograd, Robert H. Vonderheide|Cancer Immunology Research|2015

Cited by 467

Phase II Study of Maintenance Rucaparib in Patients With Platinum-Sensitive Advanced Pancreatic Cancer and a Pathogenic Germline or Somatic Variant in <i>BRCA1</i>, <i>BRCA2</i>, or <i>PALB2</i>

Kim A. Reiss, Susan M. Domchek, Rosemarie Mick et al.|Journal of Clinical Oncology|2021

Cited by 238

Neoadjuvant Selicrelumab, an Agonist CD40 Antibody, Induces Changes in the Tumor Microenvironment in Patients with Resectable Pancreatic Cancer

Katelyn T. Byrne, Robert H. Vonderheide|Clinical Cancer Research|2021

Cited by 178

Type 1 conventional dendritic cells are systemically dysregulated early in pancreatic carcinogenesis

Jeffrey H. Lin, Robert H. Vonderheide|The Journal of Experimental Medicine|2020

Cited by 175

The Impact of EBV Status on Characteristics and Outcomes of Posttransplantation Lymphoproliferative Disorder

Marlise R. Luskin, Ran Reshef, Daniel S. Heil et al.|American Journal of Transplantation|2015

Cited by 174